Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | 10% owner | December 14, 2021 | December 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date December 14, 2021 · Filed December 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 7,171,203 |
Reported balance
After 2021-12-14 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2021-12-14 · Sale · Disposed 1,000,000 · Balance 7,171,203 F1: The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities. F2: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $5.47 to $5.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 252,716 |
Reported balance
Holding disclosure · report date 2021-12-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 252,716 F4: Securities are owned by Atomic Incentives, LLC ("Incentives") and Atomic Labs, LLC ("Labs"). Labs is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives and Labs. Since the date of the last Form 4 filed by the Reporting Person, Incentives distributed 26,571 shares of Class A Common Stock to its profits interest holders, resulting in a reduction in the number of shares reported herein as owned by Incentives. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 869,279 |
Reported balance
Holding disclosure · report date 2021-12-14 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 869,279 F5: Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I. Since the date of the last Form 4 filed by the Reporting Person, Labs I distributed 434,640 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 649,776 |
Reported balance
Holding disclosure · report date 2021-12-14 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 649,776 F6: Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B. Since the date of the last Form 4 filed by the Reporting Person, Labs I-B distributed 324,888 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I-B. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 5,520,607 |
Reported balance
Holding disclosure · report date 2021-12-14 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 5,520,607 F7: Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II. Since the date of the last Form 4 filed by the Reporting Person, Labs II distributed 2,760,303 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs II. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 4,378,558 |
Reported balance
Holding disclosure · report date 2021-12-14 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 4,378,558 F8: Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person. |
| Class A Common StockSEC Table I · non-derivative | Direct | 718,598 |
Reported balance
Holding disclosure · report date 2021-12-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 718,598 |
Filing footnotes · ownership attribution and instrument terms
F1: The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities.
F2: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $5.47 to $5.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41.
F4: Securities are owned by Atomic Incentives, LLC ("Incentives") and Atomic Labs, LLC ("Labs"). Labs is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives and Labs. Since the date of the last Form 4 filed by the Reporting Person, Incentives distributed 26,571 shares of Class A Common Stock to its profits interest holders, resulting in a reduction in the number of shares reported herein as owned by Incentives.
F5: Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I. Since the date of the last Form 4 filed by the Reporting Person, Labs I distributed 434,640 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I.
F6: Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B. Since the date of the last Form 4 filed by the Reporting Person, Labs I-B distributed 324,888 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I-B.
F7: Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II. Since the date of the last Form 4 filed by the Reporting Person, Labs II distributed 2,760,303 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs II.
F8: Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2021 Filed Dec 16, 2021 21:23 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,000,000 | $5.55 | $5,548,300.00 |
DisclosureSEC source: 0001062993-21-013067 · form4.xml · nonDerivative · entry 1 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,171,203 F1 · security: The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities. F2 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $5.47 to $5.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherWarrants (right to buy) · Derivative | 24,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · derivative · entry 21 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 24,449 shares Expires 2026-01-20 F1 · derivative.exercise_price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F8 · ownership.nature: Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherWarrants (right to buy) · Derivative | 46,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · derivative · entry 20 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 46,238 shares Expires 2026-01-20 F1 · derivative.exercise_price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F7 · ownership.nature: Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherWarrants (right to buy) · Derivative | 45,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · derivative · entry 19 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 45,626 shares Expires 2026-01-20 F1 · derivative.exercise_price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F6 · ownership.nature: Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherWarrants (right to buy) · Derivative | 5,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · derivative · entry 18 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 5,422 shares Expires 2026-01-20 F1 · derivative.exercise_price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F5 · ownership.nature: Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherWarrants (right to buy) · Derivative | 7,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · derivative · entry 17 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 7,280 shares Expires 2026-01-20 F1 · derivative.exercise_price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F4 · ownership.nature: Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherWarrants (right to buy) · Derivative | 1,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · derivative · entry 16 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,559 shares Expires 2026-01-20 F1 · derivative.exercise_price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F3 · ownership.nature: Securities are owned by Atomic Incentives, LLC ("Incentives"). Atomic Labs, LLC ("Labs") is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherWarrants (right to buy) · Derivative | 4,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · derivative · entry 15 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,012 shares Expires 2026-01-20 F1 · derivative.exercise_price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F2 · ownership.direct: These securities are owned directly by the Reporting Person. The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,922 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 14 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,378,558 F9 · kind: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F9 · price: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F8 · ownership.nature: Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 33,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 13 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 8,280,910 F9 · kind: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F9 · price: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F7 · ownership.nature: Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 33,444 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 12 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 8,171,203 F9 · kind: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F9 · price: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F6 · ownership.nature: Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,989 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 11 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 974,664 F9 · kind: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F9 · price: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F5 · ownership.nature: Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,337 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 10 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,303,919 F9 · kind: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F9 · price: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F4 · ownership.nature: Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 9 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 279,287 F9 · kind: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F9 · price: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F3 · ownership.nature: Securities are owned by Atomic Incentives, LLC ("Incentives"). Atomic Labs, LLC ("Labs") is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 8 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718,598 F9 · kind: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F9 · price: Represents withholding of shares of Class A Common Stock in connection with the cashless exercises referred to in footnote (1) above. F2 · ownership.direct: These securities are owned directly by the Reporting Person. The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 24,449 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 7 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,396,480 F1 · kind: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F1 · price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F8 · ownership.nature: Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 46,238 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 6 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 8,314,803 F1 · kind: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F1 · price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F7 · ownership.nature: Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 45,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 5 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 8,204,647 F1 · kind: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F1 · price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F6 · ownership.nature: Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 5,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 4 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 978,653 F1 · kind: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F1 · price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F5 · ownership.nature: Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 7,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 3 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,309,256 F1 · kind: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F1 · price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F4 · ownership.nature: Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 1,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 2 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 280,430 F1 · kind: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F1 · price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F3 · ownership.nature: Securities are owned by Atomic Incentives, LLC ("Incentives"). Atomic Labs, LLC ("Labs") is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 19:19 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 4,012 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001196 · edgar.xml · nonDerivative · entry 1 Abraham Jack · CIK 0001841848 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 721,539 F1 · kind: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F1 · price: Represents exercise of warrants ("Warrants") to purchase shares of the Issuer's Class A Common Stock on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, the Warrant holder received .267 shares per warrant exercised and the Issuer withheld .733 shares per warrant exercised. F2 · ownership.direct: These securities are owned directly by the Reporting Person. The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.